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1053Long-Term Results for Interventions in
Patients With Pulmonary Arterial HypertensionMardi Gomberg-Maitland, Christopher Dufton, Ronald J. Oudiz, Raymond L. Benza
The currently used drugs for treating pulmonary arterial hypertension (PAH) were approved
for use based on relatively small, short-term studies of what, prior to these therapies, was a
relentlessly progressive disease. Gomberg-Maitland and colleagues note that the data
supporting the long-term therapeutic benefits of these chronic medications are primarily
derived from uncontrolled, observational studies. The available data does suggest that treated
patients are living longer than historical controls. While definitive evidence will require
randomized and properly controlled long-term trials, the current evidence supports the
long-term use of these drugs for the treatment of patients with PAH.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY1062The Valve-in-Valve Technique Can Salvage Percutaneous Aortic Valve MalpositionGian Paolo Ussia, Marco Barbanti, Angelo Ramondo, Anna Sonia Petronio, Federica Ettori,
Gennaro Santoro, Silvio Klugmann, Francesco Bedogni, Francesco Maisano, Antonio Marzocchi,
Arnaldo Poli, Massimo Napodano, Corrado Tamburino
Device malpositioning resulting in severe paraprosthetic leak after transcatheter aortic valve
implantation (TAVI) is an unfortunate outcome that can lead to hemodynamic compromise.
Ussia and colleagues review their technique for addressing this complication with implanta-
tion of a second device, called the Valve-in-Valve (ViV) technique. Only 3.6% of patients
who underwent TAVI with the 18-F CoreValve ReValving System (Medtronic, Inc.,
Minneapolis, Minnesota) required the ViV technique. There were no 30-day major adverse
cerebrovascular and cardiac events in these patients, and there was a significant improvement
in the mean transaortic gradient that was not different from those patients who underwent a
single valve deployment. These results confirm the feasibility, safety, and efficacy of the ViV
technique for revising valve malposition.(continued on page A-21)
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1069Aspirin Resistance Increases the Risk of
Early Vein Graft Thrombosis After CABG SurgeryTyler J. Gluckman, Rhondalyn C. McLean, Steven P. Schulman, Thomas S. Kickler, Edward P. Shapiro,
John V. Conte, Kathleen W. McNicholas, Jodi B. Segal, Jeffrey J. Rade
The RIGOR (Reduction in Graft Occlusion Rates) trial sought to determine whether an
incomplete response to and/or inadequate antiplatelet effect of aspirin increases the risk of
saphenous vein graft (SVG) occlusion after coronary artery bypass graft (CABG) surgery.
Aspirin responsiveness and platelet reactivity were characterized 3 days and 6 months after
CABG in subjects on aspirin monotherapy. Risk factors for SVG occlusion included target
vessel diameter 1.5 mm, short collagen/adenosine diphosphate clotting time, and elevated
urine thromboxane derivatives. These results suggest that aspirin-insensitive thromboxane
generation and shear-dependent platelet hyper-reactivity are independent risk factors for early
SVG thrombosis after CABG surgery.Editorial Comment: Robert F. Storey, p. 1078HEART RHYTHM DISORDERS1081Etiology of Fractionated Electrograms in the Posterior Left Atrium During AFFelipe Atienza, David Calvo, Jesús Almendral, Sharon Zlochiver, Krzysztof R. Grzeda,
Nieves Martı´nez-Alzamora, Esteban Gonza´lez-Torrecilla, Ángel Arenal, Francisco Ferna´ndez-Avilés,
Omer Berenfeld
Atienza and colleagues studied the mechanisms responsible for the formation of fractionated
electrograms on the posterior left atrial wall (PLAW) that have been associated with atrial
fibrillation (AF). Sustained AF was induced by pacing from a pulmonary vein (PV), and the
transitions between organized patterns and changes in electrogram morphology leading to
fractionation were studied. Transitions to fractionation were preceded by significant increases
in electrogram duration, spike number, and systolic interval shortening. These results suggest
that in paroxysmal AF, electrogram fractionation at the PLAW is a consequence of the
dynamic interaction between high-frequency re-entrant sources and the atrial anatomy.CARDIOMYOPATHY1093Cardiovascular Events in Untreated Patients With Fabry DiseaseManesh R. Patel, Franco Cecchi, Marta Cizmarik, Ilkka Kantola, Ales Linhart, Kathy Nicholls,
Jörg Strotmann, Jose Tallaj, Thi Chien Tran, Michael L. West, Dana Beitner-Johnson, Ademola Abiose
Fabry disease is an X-linked lysosomal storage disorder, which results in abnormal
accumulations of glycosphingolipids within various tissues, including the kidney and heart.
Cardiovascular disorders linked to Fabry disease include hypertension, left ventricular
hypertrophy, rhythm and conduction abnormalities, and ischemic heart disease. Patel and
colleagues analyzed data from a registry of untreated patients with Fabry disease and report
that 6% of men and 4% of women experienced cardiovascular events at mean ages of 45 and
54 years, respectively. Heart failure was the most common first cardiovascular event, which
was typically preceded by hypertension and left ventricular hypertrophy. These results suggest
that all patients with Fabry disease should be monitored for cardiovascular risk factors,
particularly hypertension and left ventricular hypertrophy.
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MARCH 1, 2011 (continued) A-22PEDIATRIC CARDIOLOGY1100Measuring IVA May Improve Detection of Myocardial Dysfunction in ChildrenSusan Lucy Roche, Michael Vogel, Oli Pitkänen, Brian Grant, Cameron Slorach, Cheryl Fackoury,
Derek Stephens, Jeffrey Smallhorn, Lee N. Benson, Paul F. Kantor, Andrew N. Redington
Roche and colleagues sought to determine the normal variation of left ventricular (LV)
isovolumic acceleration (IVA) in children as a noninvasive, load-independent index of LV
contractility and myocardial reserve. In healthy children, LV IVA was unaffected by age, sex,
weight, height, and body surface area, but did correlate with heart rate during recumbent bike
exercise, confirming a positive force-frequency relationship (FFR). Several of the children
with previous anthracycline exposure demonstrated flattened FFR curves, suggesting reduced
contractile reserve. The availability of pediatric normal values for resting LV IVA and FFR
may facilitate future investigation of LV contractility and myocardial contractile reserve during
childhood.Editorial Comment: Sa´ndor J. Kova´cs, p. 1108EXPEDITED PUBLICATIONS EXPEDITED PUBLICATIONS1111Efficacy and Safety of a Novel Inducer of ApoA-I SynthesisStephen J. Nicholls, Allan Gordon, Jan Johansson, Kathy Wolski, Christie M. Ballantyne, John J. P. Kastelein,
Allen Taylor, Marilyn Borgman, Steven E. Nissen
Apolipoprotein A-I (apoA-I) synthesis generates new high-density lipoprotein cholesterol
(HDL-C) particles, which promote reverse cholesterol transport and also exert favorable
effects on inflammatory, endothelial, and thrombotic pathways. Nicholls and colleagues
randomized almost 300 statin-treated patients with coronary artery disease to placebo or
RVX-208, the first oral agent designed to enhance apoA-I synthesis, for 12 weeks. RVX-208
produced dose-dependent increases in apoA-I, HDL-C, and large HDL-C particles.
Elevations in liver transaminases 3 times the upper limit of normal were observed in 18
patients treated with RVX-208. Further studies will be necessary to clarify if the increase in
apoA-I induced by RVX-208 improves cardiovascular outcomes with acceptable safety.Editorial Comment: Michael H. Davidson, p. 1120
